Operating Lease, Payments of Lexaria Bioscience Corp. from 31 Aug 2020 to 30 Nov 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary: Lexaria Bioscience Corp. quarterly and annual Operating Lease, Payments in USD history and change rate from 31 Aug 2020 to 30 Nov 2023.
Lexaria Bioscience Corp. Operating Lease, Payments for the quarter ending 30 Nov 2023 was $8,963, a 80% decline year-over-year.
Lexaria Bioscience Corp. annual Operating Lease, Payments for 2023 was $44,814.
Lexaria Bioscience Corp. annual Operating Lease, Payments for 2021 was $43,950, a 0.42% increase from 2020.
Source SEC data: View on sec.gov

Operating Lease, Payments, Quarterly (USD)

Operating Lease, Payments, YoY Quarterly Change (%)

Operating Lease, Payments, Annual (USD)

Operating Lease, Payments, YoY Annual Change (%)

Lexaria Bioscience Corp. Quarterly Operating Lease, Payments (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2023	$8,963	-$35,851	-80%	01 Sep 2023	30 Nov 2023	10-Q	12 Jan 2024	2023	Q1
Q4 2022	$44,814			01 Sep 2022	30 Nov 2022	10-Q	12 Jan 2024	2023	Q1
Q4 2020	$10,987			01 Sep 2020	30 Nov 2020	10-Q	14 Jan 2021	2021	Q1

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2023	$44,814			01 Sep 2022	31 Aug 2023	10-Q	12 Jul 2024	2024	Q3
2021	$43,950	+$186	+0.42%	01 Sep 2020	31 Aug 2021	10-K	29 Nov 2021	2021	FY
2020	$43,764			01 Sep 2019	31 Aug 2020	10-K	29 Nov 2021	2021	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.